Andon Health's (SHE:002432) U.S. subsidiary iHealth Labs received premarket notifications for its upper respiratory tract virus test kits, according to a Monday filing with teh Shenzhen bourse.
The test kits determine the presence of influenza A and B, COVID-19, and respiratory syncytial virus, the filing said.
The premarket notifications mean they can be sold in the U.S., the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments